Landos Biopharma secures $60M Series B round for IBD treatment

August 17, 2019
Landos Biopharma has completed a $60 million Series B round. “I am delighted to announce the closing of a $60 million Series B…
In the Journals

Patients with IBD at increased risk for type 2 diabetes

August 14, 2019
The chronic intestinal inflammation common in Crohn’s disease and ulcerative colitis appeared to increase the risk for type 2 diabetes…
In the Journals

FIT, fecal calprotectin tests can assess recurrence risk in ulcerative colitis

August 13, 2019
Results obtained through fecal immunochemical tests and levels of fecal calprotectin could help identify patients with ulcerative colitis with…
In the Journals

Smoking has no beneficial impact on UC outcomes

August 12, 2019
Patients with ulcerative colitis who smoke or have never smoked experience similar outcomes in terms of therapies they use, hospitalization and…
In the Journals

Treatment nonadherence predicts escalation in children with ulcerative colitis

August 5, 2019
Pediatric patients with ulcerative colitis who do not adhere to treatment with mesalamine may experience a decrease in therapeutic efficacy, leading…
In the Journals

Outpatient VTE linked with age, C. diff, discharge after IBD hospitalizations

July 23, 2019
Patients with inflammatory bowel disease are at increased risk for venous thromboembolism for up two months after discharge from the hospital…
In the Journals

Anti-TNF persistence lower among women with IBD

July 22, 2019
Higher rates of side effects lead to lower drug persistence of anti-TNF therapy among women with inflammatory bowel disease, according to study…
In the Journals

Remicade has not produced expected reductions in IBD hospitalizations

July 19, 2019
The introduction of Remicade as a therapy for Crohn’s disease and ulcerative colitis has not reduced the rate of disease-related…
In the Journals

IBD risk increases with Enbrel therapy for other autoimmune diseases

July 18, 2019
Patients receiving Enbrel for inflammatory diseases other than inflammatory bowel disease have an increased risk for a diagnosis of Crohn’s…
In the Journals

Anti-TNFs induce remission in ulcerative proctitis

July 11, 2019
Anti-TNF therapy helped induce clinical remission in patients with refractory ulcerative proctitis, according to study results. Guillaume